Nef-301: A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety ofNefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease(NefIgArd)

Project: Research project

Project Details

Description

Nef-301: A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)
StatusActive
Effective start/end date3/1/1812/31/26

Funding

  • CALLIDITAS THERAPEUTICS AB

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.